AstraZeneca drug selumetinib fails in lung cancer study - Reuters

Reuters

AstraZeneca drug selumetinib fails in lung cancer study Reuters LONDON AstraZeneca's cancer drug pipeline suffered a setback on Tuesday when the experimental drug selumetinib failed to meet its goal in a late-stage trial for lung cancer. Hopes for the medicine had already been reduced after it failed in another ... AstraZeneca Provides Update On Phase III Trial Of Selumetinib In Non-Small Cell Lung CancerPR Newswire (press release) AstraZeneca Cancer Drug Selumetinib Fails in Lung TrialBloomberg AstraZeneca inhibitor trial fails to meet endpointMarketWatch PharmaTimes -DIGITALLOOK -London South East (registration) (blog) all 9 news articles »

AstraZeneca drug selumetinib fails in lung cancer study - Reuters
Read More